(Q24202139)

2

0 references

Rahuram Sivasubramaniam

3

0 references

Daron Cope

4

0 references

Richard J Harvey

Cochrane Database of Systematic Reviews

5

0 references

publication date

12 December 2012

0 references

published in

0 references

cites work

Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Infections after endoscopic polypectomy using nasal steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Fluticasone propionate aqueous nasal spray does not influence the recurrence rate of chronic rhinosinusitis and nasal polyps 1 year after functional endoscopic sinus surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Functional endoscopic sinus surgery improved asthma symptoms as well as PEFR and olfaction in patients with nasal polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Efficacy and tolerability of budesonide aqueous nasal spray treatment in patients with nasal polyps

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Long-term study of fluticasone propionate aqueous nasal spray in acute and maintenance therapy of nasal polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Sensitivity of a new grading system for studying nasal polyps with the potential to detect early changes in polyp size after treatment with a topical corticosteroid (budesonide).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Efficacy and tolerability of fluticasone propionate nasal drops 400 microgram once daily compared with placebo for the treatment of bilateral polyposis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Treatment of recurrent chronic hyperplastic sinusitis with nasal polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

A double-blind comparison of intranasal budesonide with placebo for nasal polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Efficacy and safety of mometasone furoate nasal spray in nasal polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Onset of symptomatic effect of mometasone furoate nasal spray in the treatment of nasal polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Use of mometasone furoate to prevent polyp relapse after endoscopic sinus surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Prevention of relapses of nasal polyposis with intranasal triamcinolone acetonide after polyp surgery: a prospective double-blind, placebo-controlled, randomised study with a 9-month follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Preoperative treatment with topical corticoids and bleeding during primary endoscopic sinus surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Safety of meloxicam in aspirin-hypersensitive patients with asthma and/or nasal polyps. A challenge-proven study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

A randomized controlled study evaluating medical treatment versus surgical treatment in addition to medical treatment of nasal polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Reslizumab for Poorly Controlled, Eosinophilic Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

No mucosal atrophy and reduced inflammatory cells: active-controlled trial with yearlong fluticasone furoate nasal spray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

A randomized double-blind study to compare the effects of nasal fluticasone and betamethasone on the hypothalamo-pituitary-adrenal axis and bone turnover in patients with nasal polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Outcomes of middle meatal antrostomy after different surgical strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Topical furosemide versus oral steroid in preoperative management of nasal polyposis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Systemic corticosteroids for allergic fungal rhinosinusitis and chronic rhinosinusitis with nasal polyposis: a comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Glucocorticoid treatment for nasal polyps. The use of topical budesonide powder, intramuscular betamethasone, and surgical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Mometasone furoate nasal spray in the treatment of perennial non-allergic rhinitis: a nordic, multicenter, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Corticosteroid therapy increases membrane-tethered while decreases secreted mucin expression in nasal polyps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Impact of intranasal budesonide on immune inflammatory responses and epithelial remodeling in chronic upper airway inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Role of leukotriene inhibitors in the postoperative management of nasal polyps

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Regulation of glucocorticoid receptor in nasal polyps by systemic and intranasal glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Treatment of chronic rhinosinusitis and its effects on asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Preoperative corticosteroid oral therapy and intraoperative bleeding during functional endoscopic sinus surgery in patients with severe nasal polyposis: a preliminary investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Montelukast as an adjunct to oral and inhaled steroid therapy in chronic nasal polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Oral steroids and doxycycline: two different approaches to treat nasal polyps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Impact of perioperative systemic steroids on surgical outcomes in patients with chronic rhinosinusitis with polyposis: evaluation with the novel Perioperative Sinus Endoscopy (POSE) scoring system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Effect of intranasal treatment with capsaicin on the recurrence of polyps after polypectomy and ethmoidectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Pharmacological management of nasal polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Role of staphylococcal superantigens in upper airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Topical corticosteroids in nasal polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Nasal polyps: still more questions than answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

A systematic review of the use of intranasal steroids in the treatment of chronic rhinosinusitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Prevalence of nasal polyposis in France: a cross-sectional, case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Pathophysiology and progression of nasal septal perforation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Oral steroids for nasal polyps

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Rhinosinusitis: Establishing definitions for clinical research and patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Formulation considerations of intranasal corticosteroids for the treatment of allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

International Consensus on Nasal Polyposis 2002-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Nasal polyposis, eosinophil dominated inflammation, and allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Comparison of medical and surgical treatment of nasal polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Topical steroid for chronic rhinosinusitis without polyps

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Surgical versus Medical Treatment of Nasal Polyps

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

Effect of fluticasone in severe polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

Fluticasone propionate is associated with severe infection after endoscopic polypectomy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

Postoperative care for Samter's triad patients undergoing endoscopic sinus surgery: a double-blinded, randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

A double-blind labeled study of dexamethasone nasal aerosol vs. placebo in the treatment of nasal polyposis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

[Use of isotonic NaCl solution in patients with acute rhinosinusitis]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

Topical treatment of nasal polyps with a beclomethasone dipropionate powder preparation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

Budesonide nasal spray as prophylactic treatment after polypectomy (a double blind clinical trial)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

Effect of Beconase nasal spray on olfactory function in post-nasal polypectomy patients: a prospective controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

Effect of antioxidants on the clinical outcome of patients with nasal polyposis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

Do corticosteroids induce apoptosis in nasal polyp inflammatory cells? In vivo and in vitro studies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

A Short Course of Oral Prednisone Followed by Intranasal Budesonide Is an Effective Treatment of Severe Nasal Polyps

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

The effect of budesonide (Rhinocort) in the treatment of small and medium-sized nasal polyps

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin-induced asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

Clinical performance of fluticasone propionate nasal drops

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

Nasal nitric oxide in objective evaluation of chronic rhinosinusitis therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

Double blind, placebo controlled trial of betamethasone nasal drops for nasal polyposis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

Comparison of montelukast and mometasone furoate in the prevention of recurrent nasal polyps

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

The effects of fluticasone propionate on nasal epithelial potential difference.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

Comparison of conventional instruments and mechanical debriders for surgery of patients with chronic sinusitis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

Efficacy of an aqueous and a powder formulation of nasal budesonide compared in patients with nasal polyps

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

A prospective randomized blinded cross-over trial using nasal drops in patients with nasal polyposis: an evaluation of effectiveness and comfort level of two head positions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

Comparison of efficacy of mometasone furoate versus clarithromycin in the treatment of chronic rhinosinusitis without nasal polyps in Chinese adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

Effect of corticosteroids on wound healing after endoscopic sinus surgery

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

Quality of life is improved by endoscopic surgery and fluticasone in nasal polyposis with asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006549.PUB2

7 January 2021

Impact of chronic rhinosinusitis therapy on quality of life: a prospective randomized controlled trial

1 reference

COCI

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD006549.PUB2

Effective treatment of mild-to-moderate nasal polyposis with fluticasone delivered by a novel device

9 February 2024

1 reference

COCI

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD006549.PUB2

Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosol

9 February 2024

1 reference

COCI

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD006549.PUB2

10.1002/14651858.CD006549.PUB2

9 February 2024

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

23235631

1 reference

Consolidated OpenCitations Corpus – April 2017